1 recruiting, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Radiotherapy, Intensity-Modulated: new trials by email Literature Review of Radiotherapy, Intensity-Modulated trials Research Report on Radiotherapy, Intensity-Modulated
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer Trifluorouracil tepidopyrimidine, Bevacizumab, Sindilizumab - Colorectal Cancer Metastatic, Chemotherapy | Phase 2 | Recruiting | Sun Yat-sen University | 57 | 2024-12-31 | 2025-08-24 |
| A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer intensity-modulated radiotherapy, S-1 - Stomach Neoplasms, Chemoradiotherapy, Adjuvant | Phase 2 | Unknown | Chinese Academy of Medical Sciences | 60 | 2014-01-01 | 2014-11-20 |
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Stomach Diseases (1)
Bevacizumab (1) · Radiotherapy, Intensity-Modulated (1) · S 1 (combination) (1)
Chinese Academy of Medical Sciences (1) · Sun Yat-sen University (1)
China (2)